Skip to main content
Premium Trial:

Request an Annual Quote

Fred Hutchinson Center Plans Lab Support, Office Uses for New Building

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The Fred Hutchinson Cancer Research Center said it will use a newly-acquired building adjacent to its campus in Seattle's South Lake Union section for research support facilities as well as offices — and possibly could expand its lab research space as a result.

"This offers an outstanding opportunity to expand our solid tumor, infectious disease, and immunotherapy research as well as work toward the goal of consolidating all of the Center's research activities onto one campus," Doug Walker, chairman of the Hutchinson Center's board, said in a statement.

The Hutchinson Center paid $36 million to acquire the 177,000-square-foot building, at 1100 Eastlake Ave. E., from the Blume 1100 Partnership, a group of investors led by Seattle developer Bruce Blume, CEO of The Blume Company

The Hutchinson Center said in the statement that it plans to occupy the building in June 2012.

The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.